Recently, a large multicentric study by the European Network for the Study of Adrenal Tumors has demonstrated that the Ki67 labeling index (Li) is the most powerful parameter predicting disease recurrence and survival in ACC patents after complete tumor resection (Beuschlein et al., 2015). This evidence concerns the gene MKI67 and adrenal gland neoplasm.